Results 271 to 280 of about 2,154,351 (306)

Clozapine, pneumonia, and COVID-19.

Indian J Pharmacol
Sookaromdee P, Wiwanitkit V.
europepmc   +1 more source

Will there be new trends in the public's attention to express services in the post-COVID-19 era? [PDF]

PLoS One
Chen X, Gao J, Qin Q, Wang C.
europepmc   +1 more source

Booster mRNA Vaccination Prevents Breakthrough Severe COVID-19 Infections. [PDF]

J Med Virol
Dinç HÖ, Uysal HK, Can G, Budak B, Daşdemir FO, Keskin E, Aydoğan O, Balkan İİ, Karaali R, Saribaş S, Ergin S, Saltoğlu N, Kocazeybek B.   +12 more
europepmc   +1 more source

Reduced cortical brain perfusion following COVID-19 infection: impact of COVID-19 severity and relation to memory performance. [PDF]

Front Hum Neurosci
Palmer JM, Matijevic S, Ugonna C, Galdamez-Avila A, Rhodes A, Chen NK, Arias JC, Patterson D, Wang DJJ, Ryan L.   +9 more
europepmc   +1 more source

Symptom burden, lung function, exercise tolerance and inflammation in patients post COVID-19: results from the prospective COVID-19 Chronic Morbidity (CCHROMO) study. [PDF]

BMC Pulm Med
Bellinghausen C, Grünewaldt A, Azem T, Lask C, Du W, Seeger A, Herrmann E, Schubert R, Hafner J, Vehreschild MJGT, Appel TM, Rohde G.   +11 more
europepmc   +1 more source

EXPRESSION OF CONCERN: COVID-19 re-infection. [PDF]

Eur J Clin Invest
europepmc   +1 more source

COVID-19 Vaccine Effectiveness Among Older Adults.

JAMA Netw Open
Laniece Delaunay C, Mateo-Urdiales A, Pérez-Gimeno G, O'Reilly K, Uras M, Erdwiens A, Mlinaric I, Túri G, Martínez-Baz I, Meijer A, Rodrigues AP, Lazar M, Latorre-Margalef N, Lucaccioni H, Verdasca N, Bella A, Rafael de la Cruz Lopez MA, Kelly E, Enouf V, Tolksdorf K, Puzelli S, Ibáñez Pérez AC, Fitzgerald M, Masse S, Oh DY, Kaczmarek M, Bacci S, Kissling E, VEBIS Primary Care Vaccine Effectiveness Group.   +28 more
europepmc   +1 more source